In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4)

Clinical Cancer Research

Volumn 12, Issue 11 I, 2006, Pages 3485-3493

  Raffaghello, Lizzie ^a   Zuccari, Guendalina ^b   Carosio, Roberta ^a   Orienti, Isabella ^b   Montaldo, Paolo G ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 10; CASPASE 13; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; POLYMER; POLYMER P10; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; DNA CONTENT; DRUG SYNTHESIS; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MELANOMA; MICE; MICE, NUDE; NEUROBLASTOMA; POLYETHYLENE GLYCOLS; POLYVINYL ALCOHOL; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33745189991     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2318     Document Type: Article

References (27)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
2. Niethammer D, Handgretinger R. Clinical strategies for the treatment of neuroblastoma. Eur J Cancer 1995;31A:568-71.
3. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999;17:2264-79.
4. Burchill SA, Lewis IJ, Abrams KR, et al. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol 2001;19:1795-801.
5. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2:347-60.
6. Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994;15:215-20.
7. Allen TM, Ahmad I, Lopes de Menezes DE, Moase EH. Immunoliposome-mediated targeting of anticancer drugs in vivo. Biochem Soc Trans 1995;23: 1073-9.
8. Duncan R, Connors TA, Meada H. Drug targeting in cancer therapy: the magic bullet, what next? J Drug Target 1996;3:317-9.
9. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283-318.
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
11. Orienti I, Zuccari G, Carosio R, Montaldo PG. Preparation and evaluation of polyvinyl alcohol-co-oleylvinyl ether derivatives as tumor-specific cytotoxic systems. Biomacromolecules 2005;6:2875-80.
12. Pagnan G, Montaldo PG, Pastorino F, et al. GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide. Int J Cancer 1999;81: 268-74.
13. Pagnan G, Stuart DD, Pastorino F, et al. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. J Natl Cancer Inst 2000;92:253-61.
14. Ponzoni M, Bocca P, Chiesa, et al. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res 1995;55:853-61.
15. Pagnan G, Caridi G, Montaldo PG, et al. Apoptosis of human neuroblastoma induced by liposome-encapsulated fenretinide. J Liposome Res 1998;8: 401-23.
16. Bedner E, Smolewski P, Amstad P, Darzynkiewicz Z. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp Cell Res 2000;259:308-13.
17. Tabata Y, Murakami Y, Ikada Y. Tumor accumulation of poly (vinyl alcohol) of different sizes after intravenous injection. J Control Release 1998;50:123-33.
18. Raffaghello L, Pagnan G, Pastorino F, et al. In vitro and in vivo antitumor activity of liposomal fenretinide targeted to human neuroblastoma. Int J Cancer 2003; 104:559-67.
19. Fulda S, Kufer MU, Meyer E, vanValen F, Dockhorn-Dworniczak B, Debatin KM. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001;20:5865-77.
20. Banelli B, Casciano I, Croce M, et al. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med 2002;8: 1333-5.
21. Thiele CJ. Neuroblastoma. In: Masters PB, Palsson JRW, editors. Human cell culture. Vol. 1. Dordrecht (the Netherlands): Kluwer Academic Publishers; 1999. p. 21-53.
22. Bozzo C, Lombardi G, Santoro C, Canonico PL. Involvement of beta(1) integrin in betaAP-induced apoptosis in human neuroblastoma cells. Mol Cell Neurosci 2004;25:1-8.
23. Bonfoco E, Chen W, Paul R, Cheresh DA, Cooper NR. beta1 integrin antagonism on adherent, differentiated human neuroblastoma cells triggers an apoptotic signaling pathway. Neuroscience 2000;101:1145-52.
24. Zhan M, Zhao H, Han ZC. Signalling mechanisms of anoikis. Histol Histopathol 2004;19:973-83.
25. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001;13:555-62.
26. DeMerlis CC, Schoneker DR. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol 2003;41:319-26.
27. Garaventa A, Luksch R, Lo Piccolo MS, et al. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 2003; 9:2032-9.